Syringaresinol TN2250
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
(-)-Syringaresinol may be a potential chemotherapeutic agent for the treatment of cancer; it against H/R-induced cardiomyocyte injury and death, the degradation of HIF-1_ᄆ through activation of FOXO3 is a potential therapeutic strategy for ischemia-relate
CAS nr:
487-35-4
Purity:
98%
Molecular Weight:
418,4
SMILES:
COc1cc(C2OCC3C(c(cc4OC)cc(OC)c4O)OCC23)cc(OC)c1O
Formula:
C22H26O8
Pathway:
PI3K/Akt/mTOR signaling,Immunology/Inflammation,Chromatin/Epigenetic,Angiogenesis
Target:
mTOR,ROS,HIF,HIF
